Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders’ Deficit (Unaudited) - USD ($) |
Preferred Stock
Previously Reported
Series A Convertible
|
Preferred Stock
Previously Reported
Series B Convertible
|
Preferred Stock
Previously Reported
Series C/C-1 Convertible
|
Preferred Stock
Series A Convertible
|
Preferred Stock
Series B Convertible
|
Preferred Stock
Series C/C-1 Convertible
|
Common Stock
Previously Reported
|
Common Stock
NorthView Acquisition Corp
|
Common Stock |
Additional Paid-In Capital
Previously Reported
|
Additional Paid-In Capital
NorthView Acquisition Corp
|
Additional Paid-In Capital |
Accumulated Deficit
Previously Reported
|
Accumulated Deficit
NorthView Acquisition Corp
|
Accumulated Deficit |
Previously Reported |
NorthView Acquisition Corp |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2022 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | $ 5,676,000 | $ (619,995) | $ (105,447,000) | $ (619,476) | $ (99,771,000) | |||||||||
| Balance (in Shares) at Dec. 31, 2022 | 4,350,314 | 5,293,175 | 8,220,445 | 5,193,750 | 5,570,901 | |||||||||||||
| Issuance of common stock upon exercise of stock options | 23,000 | 23,000 | ||||||||||||||||
| Issuance of common stock upon exercise of stock options (in Shares) | 33,750 | |||||||||||||||||
| Stock-based compensation expense | 33,000 | 33,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (2,137,638) | (2,137,638) | ||||||||||||||||
| Excise tax payable attributable to redemption of common stock | (1,864,106) | (1,864,106) | ||||||||||||||||
| Net income (loss) | 1,161,910 | (10,281,000) | 1,161,910 | (10,281,000) | ||||||||||||||
| Balance at Dec. 31, 2023 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | $ 5,732,000 | 5,732,000 | $ (115,728,000) | (3,459,829) | (115,728,000) | $ (109,996,000) | (3,459,310) | (109,996,000) | |||
| Balance (in Shares) at Dec. 31, 2023 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Stock-based compensation expense | 5,000 | 5,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (205,732) | (205,732) | ||||||||||||||||
| Excise tax payable attributable to redemption of common stock | (10,884) | (10,884) | ||||||||||||||||
| Net income (loss) | (2,071,000) | (820,277) | (2,071,000) | (820,277) | ||||||||||||||
| Balance at Mar. 31, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,737,000 | (117,799,000) | (4,496,722) | (112,062,000) | (4,496,203) | |||||||||
| Balance (in Shares) at Mar. 31, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Balance at Dec. 31, 2023 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,732,000 | 5,732,000 | (115,728,000) | (3,459,829) | (115,728,000) | (109,996,000) | (3,459,310) | $ (109,996,000) | |||
| Balance (in Shares) at Dec. 31, 2023 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Issuance of common stock upon exercise of stock options (in Shares) | ||||||||||||||||||
| Accretion of common stock to redemption value | (387,062) | |||||||||||||||||
| Net income (loss) | (1,217,764) | $ (4,481,000) | ||||||||||||||||
| Balance at Jun. 30, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,743,000 | (120,209,000) | (5,075,539) | (114,466,000) | (5,075,020) | |||||||||
| Balance (in Shares) at Jun. 30, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Balance at Dec. 31, 2023 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,732,000 | 5,732,000 | (115,728,000) | (3,459,829) | (115,728,000) | (109,996,000) | (3,459,310) | (109,996,000) | |||
| Balance (in Shares) at Dec. 31, 2023 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Issuance of common stock upon exercise of stock options | ||||||||||||||||||
| Issuance of common stock upon exercise of stock options (in Shares) | ||||||||||||||||||
| Stock-based compensation expense | 21,000 | $ 21,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (768,980) | (768,980) | ||||||||||||||||
| Excise tax payable attributable to redemption of common stock | (16,838) | (16,838) | ||||||||||||||||
| Net income (loss) | (8,711,619) | (9,230,000) | (8,711,619) | (9,230,000) | ||||||||||||||
| Balance at Dec. 31, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,753,000 | 5,753,000 | (124,958,000) | (12,957,266) | (124,958,000) | (119,205,000) | (12,956,747) | (119,205,000) | |||
| Balance (in Shares) at Dec. 31, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Balance at Mar. 31, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,737,000 | (117,799,000) | (4,496,722) | (112,062,000) | (4,496,203) | |||||||||
| Balance (in Shares) at Mar. 31, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Stock-based compensation expense | 6,000 | 6,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (181,330) | (181,330) | ||||||||||||||||
| Net income (loss) | (2,410,000) | (397,487) | (2,410,000) | (397,487) | (2,071,000) | |||||||||||||
| Balance at Jun. 30, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,743,000 | (120,209,000) | (5,075,539) | (114,466,000) | (5,075,020) | |||||||||
| Balance (in Shares) at Jun. 30, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Balance at Dec. 31, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,753,000 | 5,753,000 | (124,958,000) | (12,957,266) | (124,958,000) | (119,205,000) | (12,956,747) | (119,205,000) | |||
| Balance (in Shares) at Dec. 31, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Stock-based compensation expense | 5,000 | 5,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (155,999) | (155,999) | ||||||||||||||||
| Excise tax payable attributable to redemption of common stock | (65,108) | (65,108) | ||||||||||||||||
| Net income (loss) | (2,716,000) | (1,119,910) | (2,716,000) | (1,119,910) | ||||||||||||||
| Balance at Mar. 31, 2025 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,758,000 | (127,674,000) | (14,298,283) | (121,916,000) | (14,297,764) | |||||||||
| Balance (in Shares) at Mar. 31, 2025 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Balance at Dec. 31, 2024 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,753,000 | $ 5,753,000 | (124,958,000) | (12,957,266) | $ (124,958,000) | (119,205,000) | (12,956,747) | $ (119,205,000) | |||
| Balance (in Shares) at Dec. 31, 2024 | 4,350,314 | 5,293,175 | 8,220,445 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | 5,604,651 | |||||||||
| Issuance of common stock upon exercise of stock options (in Shares) | ||||||||||||||||||
| Accretion of common stock to redemption value | (164,969) | |||||||||||||||||
| Net income (loss) | (9,316,786) | $ (5,064,000) | ||||||||||||||||
| Balance at Jun. 30, 2025 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,840,000 | (130,022,000) | (22,510,739) | (124,182,000) | (22,510,220) | (124,182,000) | ||||||||
| Balance (in Shares) at Jun. 30, 2025 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Balance at Mar. 31, 2025 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | 5,758,000 | (127,674,000) | (14,298,283) | (121,916,000) | (14,297,764) | |||||||||
| Balance (in Shares) at Mar. 31, 2025 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 | |||||||||||||
| Stock-based compensation expense | 82,000 | 82,000 | ||||||||||||||||
| Accretion of common stock to redemption value | (8,970) | (8,970) | ||||||||||||||||
| Excise tax payable attributable to redemption of common stock | (6,610) | (6,610) | ||||||||||||||||
| Net income (loss) | (2,348,000) | (8,196,876) | (2,348,000) | (8,196,876) | (2,348,000) | |||||||||||||
| Balance at Jun. 30, 2025 | $ 5,231,000 | $ 13,701,000 | $ 46,217,000 | $ 519 | $ 5,840,000 | $ (130,022,000) | $ (22,510,739) | $ (124,182,000) | $ (22,510,220) | $ (124,182,000) | ||||||||
| Balance (in Shares) at Jun. 30, 2025 | 4,350,314 | 5,293,175 | 8,220,445 | 5,604,651 | 5,193,750 |